MRC CECH News
- "New approach to recording suspected child abuse in patient records (press release)"
- Staff 'too timid' on child abuse (Reaction to a series of articles on child abuse published in the Lancet medical journal).
- 'PhD student writes about her internship experience with the Academy of Medical Sciences and Medical Research Council gaining an insight into the medical policy environment'.
- Carol Dezateux awarded WellChild Researcher of the Year 2012
- Centre Director presents at international paediatrics conference
- Parents regaining confidence in MMR vaccine
- Researcher Starts MRC Fellowship
- Response to 'HIV baby cure' headlines
- Importance of MMR Vaccine
- Half of all UK 7 year-olds not getting enough exercise
- Centre's work on HIV in pregnancy highlighted in UNAIDS HIV
- Professor Ruth Gilbert is Clinical Lead for Research on UK's largest study of child mortality
- World AIDS Day 2013
What we do
We teach and carry out research to improve children's health and wellbeing and to
prevent, diagnose and treat conditions that might affect them in
childhood or in later life.
We develop and apply statistical methods to complex research data and train researchers to use these methods.
We work with researchers from other disciplines and those who use our work to ensure that our research gives children the best possible start in life.
Response to 'HIV baby cure' headlines
21 March 2013
Senior Lecturer at the Centre, Dr Pat Tookey, was interviewed on the BBC News Channel, and participated in a 3-way live radio discussion on Voice of Russia.
Researchers in the United States say early treatment of a baby born with HIV appears to have all but eradicated the virus from her body – they are calling it a ‘functional cure’. Dr Pat Tookey, who runs the National Study of HIV in Pregnancy and Childhood at UCL ICH, and collects the UK data on HIV in pregnancy, was interviewed on the BBC News Channel about the report, and participated in a live 3-way London/Washington/Moscow discussion on Voice of Russia Radio. "That is incredibly unusual, great news for this mother and baby, but really they need to follow that baby up to be sure she continues to keep the virus suppressed”, she said. “Research on effective treatments is vital, but the best treatment of all is prevention of infection in the first place. Here in the UK, all pregnant women are offered screening for HIV in pregnancy, and most diagnosed women (about 1300 a year currently) take anti-HIV drugs in pregnancy and avoid breastfeeding. All but a handful of their babies are born free of the virus – a transmission rate of around 1 in 200, or even less. In this American case, the mother had no antenatal care and so no opportunity for treatment which would probably have prevented the baby becoming infected.” Guidelines in the UK already recommend a triple-drug cocktail, to be started within 4 hours of birth, for infants at higher risk of infection – those whose mothers are only diagnosed at the time of delivery, or who still have circulating virus close to the time of the baby’s birth. If the baby turns out to be uninfected (which is almost always the case) the drugs are stopped after 4 weeks; the very few infected infants continue on treatment.
Functional HIV cure after very early ART of an infected infant http://www.retroconference.org/2013b/Abstracts/47897.htm
Radio discussion http://ruvr.co.uk/2013_03_08/HIV-AIDS-cure-medicine/
BHIVA Guidelines on Management of HIV in pregnant women http://www.bhiva.org/Guidelines.aspx
UK data available on the NSHPC website http://www.ucl.ac.uk/nshpc
Page last modified on 21 mar 13 12:57